{"database": "lobbying", "table": "lobbying_activities", "rows": [[1444203, "51c89a96-4571-4cf0-9899-85d930296e4f", "Q3", "RED+BLUE STRATEGIES", 400693064, "PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA)", 2013, "third_quarter", "PHA", "H.R. 1367 - FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act  - focused on policies that would negative impact peoples access to prescription medications through mail.\n\nIssues related to the practice of giving coupons for certain prescription medications.Ongoing discussions in the Congress regarding track and trace policies to increase safety in the nation's prescription drug supply chain.\n\nCMS call letter focused on changes in policies regarding mail order and pharmacy networks.", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2013-10-16T13:46:39.087000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1444203"], "units": {}, "query_ms": 32.890612026676536, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}